ANI Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

ANI Pharmaceuticals

09/08/2023 14:32

* ANI Pharmaceuticals Inc  ANIP.OQ  reported quarterly
adjusted
earnings of $1.28​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was
for earnings of 68 cents per share.
    * Revenue rose 57.8% to $116.55 million from a year ago;
analysts
expected $98.70 million. 
    * ANI Pharmaceuticals Inc's reported EPS for the quarter was
29
cents​.
    * The mean earnings estimate of analysts had risen by
about 2.7%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * ANI Pharmaceuticals Inc shares had risen by 3.9% this
quarter and gained 39.0% so far this year.
    * The company reported quarterly net income of $5.84
million.
    * Wall Street's median 12-month price target for ANI
Pharmaceuticals Inc is $60.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      0.68           1.28           Beat
 Mar. 31 2023      0.35           1.17           Beat
 Dec. 31 2022      0.67           0.76           Beat
 Sep. 30 2022      0.55           0.64           Beat